Integra LifeSciences Holdings Corporation reported $380.8 million in sales and $8.15 million in operating loss for the quarter ending September 30, 2024, which beat both Wall Street’s expectations and management’s guidance.
Company News Premium
Integra LifeSciences Puts Tough Third Quarter in Perspective
1 min read Premium comments

Premium#integra#3q24earnings
React:
